Pages

Showing posts with label Healthcare. Show all posts
Showing posts with label Healthcare. Show all posts

Friday, February 15, 2019

Whole Slide Imaging Market Restraint Analysis, Product Estimates & Forecast by 2018


The global Whole Slide Imaging Market is likely to display a momentous growth in the near future owing to augmentation in the applications and expansion of the scope across various sectors. Whole Slide Imaging can be defined as a procedure that incorporates scanning of glass slides in order to generate digital slides. It can be abbreviated as WSI. The process is also popularly known as virtual microscopy. It is said that the technique was promoted particularly for analytical, educational as well as research activities. While employing the method for remote frozen section identification, it calls for an in depth execution period along with skilled support staffs. The Whole Slide Imaging Industry is attaining huge recognition across various sectors owing to burgeoning demands and prerequisites.

It is significant that the Whole Slide Imaging market is budding at a higher CAGR. The prime causes for the positive market growth may encompass may include robust industrialization, rapid urbanization, technological advancements, burgeoning demands among the end users, product differentiations, technological innovations, rising applications, constant innovations, rising prerequisites, and augmentation in the investments by the leading manufacturers.


Also, the manufacturers are taking up various strategies such as partnerships, acquisitions, and joint ventures that is ultimately contributing in the inorganic growth of the Whole Slide Imaging Market. On account of all the above factors, it is estimated that the Whole Slide Imaging Industry will register a healthy CAGR in the upcoming period. This industry can be split up by type of radioisotope, application, and geography. The industry is type of radioisotope as Thallium-201 (TL-201), Technetium-99m (TC-99m), Iodine (I-123), and others. This market is divided by application as Cardiology, Lymphoma, Thyroid, Neurology, and others. Whole Slide Imaging Industry is segmented by geography as North America, Europe, China, Japan, Southeast Asia, and India.


Geographically, North America is holding the largest share in the market and it is simultaneously holding a considerable share in the Whole Slide Imaging market owing to developed economies, rise in the level of awareness among the end users, and augmentation in the investments by the leading manufacturers. On the other hand, Asia Pacific as well as European regions are also expanding in the market owing to emergence of the market growth opportunities in these regions. The prominent players contributing in the robust development of the Whole Slide Imaging Industry are identified as Agfa-Gevaert N.V., Siemens, Positron Corporation, Gamma Medica Inc., GE Healthcare, Hologic Inc., CardiArc Ltd., Digirad Corporation, and Philips.

Tuesday, January 22, 2019

Blood Screening Market|Technology Overview & Vendor Landscape, 2024

22 Jan 2019 - Global Blood Screening Market is anticipated to reach USD 3.9 billion by 2024. It is anticipated to grow at a healthy rate in the years to come. Blood is a living tissue made up of liquid, with several proteins and cells suspended in it. It contains red blood cells, circulating fluid, platelets, and white blood cells. It offers nutrition and oxygen to the body cells through arteries, capillaries, and veins. It also helps in removal of carbon dioxide and metabolic waste from the body. Blood screening implies medical procedure wherein blood is inspected for a specific condition or disease. It helps to monitor health issues & diseases and a chronic ailments such as cancer and infections.

blood screening market

The facts that propel the growth of the Market include surge in adoption of nucleic acid amplification test (NAT), increase in prevalence of infectious diseases, rise in awareness regarding healthcare, and increase in the number of blood donations. Furthermore, surge in healthcare expenditure, increase in healthcare initiatives by government, and technical developments in blood screening technologies have resulted in the market growth. On the other hand, factors such as dearth of skilled manpower, high operating costs, and strict regulatory approvals may hinder the market development. The introduction of pathogen reduction technology and microbiology screening & multiplexing are anticipated to offer profitable opportunities for the blood screening market. and grow at a significant CAGR of 10.2% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Blood Screening Market may be analyzed based on technology, product outlook, end users, and geography. The Market may be explored by technology as ELISA, Chemiluminescence Immunoassay (CLIA), and Enzyme Immunoassay (EIA), Nucleic Acid Amplification Test (NAT), Western Blotting, and Next-Generation Sequencing (NGS). The NAT may be further split into real-time PCR and transcription-mediated amplification (TMA). The “NAT” dominated the blood screening market in 2016 and is anticipated to maintain its dominance by 2024 due to growing number of blood donations, increasing occurrence of transferrable diseases, and growing disposable income with respect to reimbursement for NAT-tested blood.

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/blood-screening-market/request-sample

Furthermore, the increasing consciousness about advanced and innovative applications of NAT in disease screening and the growing demand for safe donated blood by patients suffering from thalassemia, hemophilia, and sickle-cell anemia boost the development of this technology sector. Blood Screening Market may be explored by product outlook as Reagent& kit, and Instrument.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/blood-screening-market

The market may be analyzed based on end user into Blood Banks, and Hospitals. The “blood banks” segment dominated the market in 2016 and anticipated to maintain its dominance by 2024 due to factors such as growing demand for donated blood, rising number of rising awareness regarding the safety of blood, organ transplantation surgeries, growing number of donations worldwide, and development in government funding to charitable trusts. North America accounted for the major share of the global Blood Screening Industry in 2016 and will continue to lead in the forecast period due to factors such as growing participation of several government associations in screening & transfusion activities and blood donations, and rising adoption of nucleic acid tests (NAT). Some of the key players that fuel the growth of the Blood Screening Market include Becton, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd, Grifols, Dickinson and Company, Ortho Clinical Diagnostics, Siemens AG, and Thermo Fisher Scientific Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Friday, January 18, 2019

Bioactive Wound Care Market Snapshot & Growth Prospect Mapping|2024

18 Jan 2019 - The global Bioactive Wound Care Market was valued at USD 6.9 billion in 2015 and is anticipated to reach USD 11.9 billion by 2024, with a CAGR of 6.3%. Bioactive wound care market is now at the budding stage with an enormous chance to seize over usual wound care market. The Bio Active Wound Care equipment’s are utilized to take care of chronic injuries which are arterial or venous ulcers and foot ulcers. The Bioactive Wound Care devices are used to treat ulcers without the use of surgical methods such as stapling. The focus is on natural healing of the ulcer through the development of epithelialization and wound contraction. The biological wound bandage work upon the injured area to begin the curative process. Biological dressings are capable of maintaining a neutral pH and reducing the alkalinity. The biological dressings soak up exudates which assist in maintaining the wetness around the injury. Re-epithelialization is merely probable if there is a guarded environment with required pH, oxygen and humidity.

bioactive wound care market

Bioactive Wound Care Market is budding with the beginning of superior technologies. The aged inhabitants are on the rise, which are mainly prone to skin injuries. The augmented consciousness about healthcare and the rising requirement for bioactive material is expected to drive the market over the forecast period. Bioactive wound care market is also obsessed by the augmented utilization of grafting. Persistent Diseases such as cancer cause wounds, diabetes, are also expected to increase the use of bioactive wound bandage. The purpose of bioactive wound bandages is to decrease the curative time which will reduce the overall charge for the patient. The significance of bioactive wound bandages is expected to increase over the forecast period owing the proven effectiveness of its constructive effect on wound curing procedure. Though, the existence of alternative to bioactive wound care goods could pose a challenge to the growth of bio active wound care market over the forecast period. Utilization of Growth Factors and Synthetic Protein Matrix in Wound therapeutic is expected to drive growth over the forecast period.

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/bioactive-wound-care-market/request-sample

The bioactive wound care market comprises of a wide spread manufactured goods line with various type of bandages such as Honey based bandages, Silver based bandages, Silicone based bandages, Collagen based bandages, and Alginate based bandages. Every product type is designed to treat various types of wound such as venous leg ulcers, diabetic foot ulcers, full thickness burns and traumatic wounds. The market for Silver bandages is expected to be the chief driver in the growth of bioactive wound care market over the forecast period. The requirement for honey bandages is expected to be comparatively low owing to the high utilization of enhanced bioactive wound bandages such as foam dressings and alginate dressings. On the basis of geographical regions, the market can be segregated into Asia-Pacific, North-America, Europe and RoW.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/bioactive-wound-care-market

North America is expected to have the major market share over the forecast period followed by European region. The augmented per capita expenditure on Healthcare and change towards aging inhabitants is expected to drive the market in North-America. The chief reasons which are expected to fuel the growth of North-America`s market growth is rising aged population in the USA. The Bioactive Wound Care market in the US is also expected to witness increased adoption of antimicrobial bandages. Asia Pacific region is expected to witness the major expansion owing to growing population coupled with increased requirement for advanced healthcare.

The key players operating in this market are 3M Healthcare, Covidien, Smith & Nephew plc, Acelity, Inc and Smith & Nephew plc. In past few year, Smith& Nephew has Moved into rapidly increasing Bioactive Wound Care section by Health Point Bio therapeutics acquirement. At Present, extensive research is being carried out for getting the idea about effectiveness of growth factors in cure of wounds. Growth Factors are taken out from animal tissue and human tissue. Though, there has been a set of arguments on employing growth factors. The subject of cost and safety has exaggerated the transformation of growth factors to medical trials. The chief problem linked with the utilization of growth factors is that good delivery systems are necessary for successful wound remedies. The focus of companies is on making recombinant growth factors. The benefit with recombinant growth factors is, risk linked with disease diffusion is decreased to a huge extent. TGF-beta 3, VEGF and EGF are the three growth factors that are proven to be effectual in wound remedies. Companies in this market require conducting additional number of medical trials to do the analysis of the positive outcome of growth factors in wound remedies.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Thursday, January 17, 2019

Pulmonary Arterial Hypertension (PAH) Market: Snapshot, Application & Research Methodology To 2025

17 Jan 2019 - The global Pulmonary Arterial Hypertension (PAH) Market size was valued at USD 5.0 billion in 2015 and is anticipated to reach USD 8.7 billion by 2025. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. These arteries are called pulmonary arteries. PAH occurs when the pulmonary arteries thicken or grow rigid. PAH is one of the five groups of pulmonary hypertension, classified by the World Health Organization (WHO).

pulmonary arterial hypertension (pah) market

The market for PAH is growing moderately due to newer launches of pipeline drugs that target different pathways to suppress the symptoms of the disease. Early diagnosis of the disease has played a pivotal role in number of patients undergoing treatment. Globally the PAH market is segmented on the basis of Drug class, Surgery, and region. On the basis of Drug class, the global PAH market is classified into Endothelin Receptor Antagonists (ERAs) (Tracleer, Opsumit, Letairis)- These medications reverse the effect of endothelin, a substance in the walls of blood vessels that causes them to narrow; Prostacyclin and Prostacyclin Analogs- were the first medications approved by the U.S. FDA for the treatment of PAH. Phosphodiesterase-5 (PDE-5) V Inhibitors, Sildenafil, and Tadalafil- Revatio, Viagra, Cialis, etc. These drugs work by opening the blood vessels in the lungs to allow blood to flow easily. These drugs have superiority over existing therapy options with respect to the therapeutic efficacy, route of administration, and side-effects.

A new drug called Uptravi (selexipag), which is a selective IP prostacyclin receptor agonist, is expected to be launched in 2016 and is likely to drive growth of the prostacyclin and prostacyclin analogs market. The rising sales of these newly-approved therapeutic agents are likely to contribute to the overall revenue of the market.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/pulmonary-arterial-hypertension-pah-market/request-sample

Globally, regulatory bodies have granted an Orphan Drug Designation (ODD) status to all those drugs intended to diagnose and treat or cure a rare disease. In the U.S., the Orphan Drug Act (ODA) encourages pharmaceutical industries to develop orphan drugs by offering benefits such as tax credits, research grants, and orphan drug exclusivity of seven years. These benefits are escalating the development, manufacturing, and marketing of drugs intended to treat PAH, thereby driving market growth.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/pulmonary-arterial-hypertension-pah-market

On the basis of surgeries, the global PAH market is classified into Atrial Septostomy- This is an open heart surgery; in which surgeon will create an opening between the upper left and right chambers of your heart to relieve the pressure on the right side of heart. Transplantation- Lung or heart-lung transplant might be an option especially for younger people who have idiopathic pulmonary arterial hypertension. Geographically, PAH market is segmented into North America, Europe, Asia Pacific, Latin America, MEA, and Rest of the World. North America held the maximum share of market for PAH in terms of revenue in 2013, which is then followed by Europe. These two developed regions are expected to witness substantial growth during the forecast period, due to the recently approved PAH drugs in the market and the products that are anticipated to receive approval during the next few years. In the Asia Pacific region, Japan, China, India, Australia, and New Zealand exhibit immense opportunities for the companies operating in the PAH market.

The low level of awareness regarding the diagnosis and treatment of PAH is one of the prime reasons restraining the market growth in MEA and rest of the world. The patent expirations of major PAH drugs along with the availability of generic drugs are expected to adversely affect the overall revenue of the market. Some of the major players in the market are Actelion Pharmaceuticals, Ltd., Bayer HealthCare, Gilead Sciences, Inc., GlaxoSmithKline plc, Novartis International AG, Pfizer, Inc. and United Therapeutics Corporation are the key players operating in the global PAH market.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Wednesday, January 16, 2019

Women’s Health Market Categorization, Product Estimates & Trend Analysis 2025

16 Jan 2019 - The global Women’s Health Market size was valued at USD 36.5 billion in 2016 and is expected to reach USD 51.3 billion by 2025, with a CAGR of 3.9%. Being a man or a woman has an important impact on health; as a result of both biological and gender-related differences. The health of women and girls is of particular concern because in many societies they are disadvantaged by judgment rooted in sociocultural factors. The general practice management of women’s health involves a general patient-centered approach toward the physical, mental, and emotional health of women, their families, and their relationships. Women’s health needs to be understood in the perspective of their psychological and cultural environment.

women_s health market

In 1900, a woman’s lifespan was about 50 years but now in the new millennium, average life expectancy for American women is 82 years of age, and it is continuing to rise. Gynecology is the primary branch of medical science concerned with women’s health issues. The National Institutes of Health (NIH) established Women’s Health Initiative (WHI) in 1991 to address the most common causes of death, disability, and impaired quality of life in postmenopausal women. The Agency of Healthcare Research and Quality (AHRQ) supports research on all aspects of healthcare provided to women. With many countries pitching for improving the healthcare facilities for women, the market for women’s health will have a positive viewpoint in the years to come. As a part of social security measure many countries have considerably increased their healthcare budgets. The U.S. government spent 17% of their GDP on the healthcare sector in 2014.

Women’s Health Market is segmented on the basis of application and analysis, drug class, and region. Segmentation by application and analysis of women’s health market covers Postmenopausal osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic ovary syndrome (PCOS).

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/womens-health-market/request-sample

Endometriosis is a problem affecting a woman’s uterus; the place where a baby grows when a woman is pregnant. The misplaced tissue can cause pain, infertility, and very heavy periods. Polycystic ovary syndrome happens when a woman’s ovaries or adrenal glands produce more male hormones than normal. Women with PCOS are at higher risk of developing diabetes and heart disease. Women who can get pregnant but unable to stay pregnant is also considered as infertile. About 10% (6.1 million) of women in United States aged 15-44 years have difficulty getting pregnant or staying pregnant. A woman has reached menopause when she has not had a period for 12 months in a row (45-55 age). Menopause happens because the woman’s ovary stops producing the hormones estrogen and progesterone.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/womens-health-market

Contraception is a method of birth control available to prevent unintended pregnancy. Osteoporosis is of major concern among post-menopausal women and this disease is projected to affect around 20 percent of post-menopausal women. The disease is characterized by substantial loss of bone mass and increasing the risk of serious fractures. Currently the menopause therapeutics market is determined by hormone therapeutics. In 2015, the postmenopausal osteoporosis segment conquered the market and accounted for more than 37% of the market share. Market size by drug class includes Evista, Xgeva, Mirena, Zometa, Minastrin 24FE, Nuvaring, Forteo, Premarin, Actonel, Ortho-Tri-Cy LO 28, and Reclast. On the basis of geography, women’s health therapeutics market size comprises four major regions: North America, Europe, Asia Pacific, and Rest of the World. North America and Europe are the foremost markets for women health therapeutics. This is because of increased awareness regarding women health. Contraception and fertility control are supported by the governments of developing countries such as India and China to curb the growing population. This trend is expected to show positive growth of women’s health market from 2014 to 2025. The key players of women’s health market are Allergan, Bayer Healthcare, Merck, Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, Ferring International Center.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Friday, January 11, 2019

Women’s Health Diagnostic Testing Market Segmentation & Growth Prospect Mapping|2025

11 Jan 2019 - The global Women’s Health Diagnostic Testing Market is expected to witness an exponential growth over forecast year. The NIH Revitalization Act was formulated in 1993 with a vision to determine the best knowledge about gender and ethnicity differences and similarities and also made women health a national priority. Efforts are now made in order to ensure a healthy lifestyle for women to conform to the laid vision. In terms of healthcare and on a global scale, a high number of women suffer from diseases such as cardiovascular, lung cancer, depression, Alzheimer and urinary contingencies and owing to growth in medical infrastructure across the world and so a higher proportion of women get a timely diagnosis. On the basis of geographic segmentation, the global women’s health diagnostic testing market spans North America, Europe, Middle-East, Asia-Pacific and Africa.

women_s health diagnostic testing market

On a commercial basis, women have distinctive health issues such as menopause, pregnancy and other minor ailments pertaining to fertility. So, with the rise in number of female patients for distinct diseases, the market for women’s health and diagnostic testing market is gaining a positive traction which is likely to augment the market growth in distant future. The key driving factors responsible for the growth of women’s health diagnostic testing market include rising awareness in patients with regards to healthcare concerns, growing research for detection of several type of cancers and prevention of disease. Additionally, women’s health diagnostic market also witnesses a significant growth during the forecast period owing to government initiatives and public awareness campaigns. Moreover, the market is rising due to favorable reimbursement of medical policies and medical coverage for diagnosis & treatment of disorders.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/womens-health-diagnostic-testing-market/request-sample

However, factors such as patient’s unwillingness for early screening which need heavy expenditures for detections, risk over diagnosis and overtreatment, expensive MRI scans and medicines are likely to impede the market growth during the forecast period.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/womens-health-diagnostic-testing-market

On the basis of tests conducted, the global women’s health diagnostic testing market is segmented into pregnancy & ovulation, bone density testing, prenatal screening, mammography, pap smears or cervical cancer screening, colposcopy, HPV testing, ovarian cancer, urinary tract infections, cystic fibrosis, and autoimmune diseases. On the basis of prostate cancer screening, the global women’s health diagnostic testing market is segmented into hospitals, clinics, home healthcare, research labs, diagnostics and imaging centers and cancer institutes. North America leads the global market owing to advanced healthcare infrastructure, growth in per-capita income, emphasis on multinational device manufacturing companies and enhancement of MNC’s. Europe is anticipated to grow during the forecast period owing to growth in regulations by various medical organizations such as WHO. Besides, increased funding in public and private sector is propelling the market growth. APAC regions are anticipated to grow during the forecast period owing to growth in healthcare scenarios in the regions such as India and China. The key players in the global women’s health diagnostic testing market include Nova Biomedical, Quest Diagnostics Inc., Abbott Laboratories, GE Healthcare, Alere Inc., Hologic, Inc.,F. Hoffmann-La Roche AG, Becton, PerkinElmer Inc., Dickinson and Company, bioMérieux SA, Koninklijke Philips N.V, Siemens Healthcare Diagnostics

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Wednesday, January 9, 2019

Asthma Market|Product Estimates & Emerging Trend Analysis 2025

9 Jan 2019 - Asthma is a lung disease; i.e. a chronic condition that causes inflammation and narrowing of the bronchial tube (the passageways that permit air to pass in and leave the lungs). Some of the symptoms of asthma include shortness of breath, coughing, wheezing and chest tightness. The factors that propel the Asthma Market size include innovation in drugs, rising occurrences of asthma cases, mounting geriatric population, rising number of smokers, growth in the disposable income, developing healthcare infrastructure and facilities, and intensifying pollution level.

asthma market

On the other hand, there are also factors that hinder the global Asthma Market size such as the patent expiry of drugs, high expenditure on treatment, and growth in use of generic drugs. The global Asthma Market size spans type, device type, drug type, route of administration, and geography. On the basis of type, the global Asthma Market size constitutes allergic asthma and non-allergic asthma. The allergic asthma is basically caused due to exposure to allergens like pollens from weeds, trees, etc., dust, and so on. On the other hand, the non-allergic asthma is basically caused due to exercise, stress, cold, flu, etc. On the basis of device type, the global Asthma Market size constitutes inhalers and nebulizers. The “inhalers” segment is further sub-categorized as dry powder, soft mist inhalers (SMIs), metered dose inhalers (MDIs). Nebulizers are devices that carry the drug in a fluid form that is dispensed by the compressed air. The “nebulizers” segment is further sub-categorized as mesh nebulizers, compressor nebulizers, and ultrasonic nebulizers. In 2015, the metered dose inhalers (MDIs) accounted for the largest share of the global Asthma Market owing to the ease of availability, consistency, portability, flexibility, and cost-effectiveness. The features like portability, noteworthy benefits in the home healthcare applications, and ideal design that enables dispense medication directly to the respiratory track are estimated to offer prospective growth opportunities for its high utility.

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/asthma-market/request-sample

On the basis of drug type, the global Asthma Market size spans anti-inflammatory, immunosuppressant, bronchodilators, mast cell stabilizers, leukotriene antagonists, and combination of ICS/LABA. In this segmentation, the combination drug type consisting of inhaled corticosteroids with long-acting beta agonists dominated the global Asthma Market in 2015. The factors that attribute to the large share of combination drug type are rise in application rates due to twofold action of combination therapy and its high efficacy rate.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/asthma-market

On the basis of route of administration, the global Asthma Market size spans inhaled, oral, intravenous, and subcutaneous. The inhaled route of administration accounted for the largest market share of the Asthma Market in 2015.  On the basis of geography, the global Asthma Market size constitutes North America, Europe, Asia Pacific, and Rest of the World. North America holds the largest share of the global Asthma Market due to rising number of asthma patients, increase in geriatric population, drug innovation, high-tech advancement, and developed healthcare infrastructure. The North American market is tracked by Europe. During the forecast period, the Asia Pacific’s market is projected to witness a high growth rate owing to factors such as rise in population, increasing number of asthma patients, emerging healthcare infrastructure and facilities, environmental pollution, growing disposable income, and enlarging number of smokers. Some of the prominent players that fuel the growth of the Asthma Market include AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc., and Baxter International.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Tuesday, January 8, 2019

Choroidal Neovascularization Market Size, Methodology, Trends & Scope by 2025

8 Jan 2019 - Choroid is principally that portion of eye that lies in between the retina and the sclera. It is said that this particular region of eye comprises of blood vessels that constantly offers nutrients to the retinal part of our eye. Choroidal Neovascularization (CNV) Market size on the basis of methods of diagnosis spans Fluorescein Angiography (FA), Indocyanine Green (ICG) angiography, and spectral domain Optical Coherence Tomography (OCT).

choroidal neovascularization market

Choroidal Neovascularization (CNV) is an ailment, that is distinguished by the formation of new blood vessels that evolve either because of the existence of Vascular Endothelial Growth Factors or because of Age-related Macular Degeneration (AMD). It has been noted that this particular disease is quite prominently occurring in the population with flaws in the inmost stratum of the choroid known as Bruch's membrane. It is linked with the production of new blood vessels in the choroidal layer of eye. These blood vessels may suddenly break into the retina and give rise to disruption as well as sight loss/vision loss. The key symptoms of this disorder may encompass loss of vision, metamorphopsia, paracentral or central scotoma, and apparent change in image size. This disease frequently takes place among the aged group of population and among people who are suffering from severe myopia. Among all, Fluorescein Angiography (FA) is the most frequently employed diagnosis technique.

And now days, it has been observed that the method of spectral domain OCT has occupied the position of FA, the reason being its attached benefits and highly accurate treatment provided by it. The studies show that CNV very often originate from posterior pole lesions and therefore it becomes quite difficult to spot and identify. Thus, it is very essential to take up an accurate and precise diagnosis in order to get relief from CNV. Researchers have identified a wide range of diagnosis methods of CNV along with various treatments. As far the treatments are concerned, the prominent ones include angiogenesis inhibitors injection, photodynamic therapy, laser photocoagulation, low dose radiation therapy as well as surgery.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/choroidal-neovascularization-cnv-market/request-sample

Among all these mentioned treatments, it is said that angiogenesis inhibitor injection is the most traditional technique to administer the development of blood vessels by decreasing the area of fluid that is just below the retinal pigment epithelium.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/choroidal-neovascularization-cnv-market

The prominent factor that is playing a major part in raising the Choroidal Neovascularization (CNV) market share include high rate of increment in CNV affected patients owing to augmented aged population. In addition, the concerned government authorities and heath care departments across the globe are taking up various initiatives for raising awareness among the masses regarding the disease. Plus, they are offering appropriate diagnosis and treatments at reasonable prices. This is in turn assisting in compelling the overall growth of Choroidal Neovascularization (CNV) market. The only factors that are turning as major hurdles in the market growth include high lack of awareness among masses especially in the African and Asian regions regarding various kinds of eye diseases and soaring cost attached with its treatment.

Additionally, inaccessibility of better healthcare infrastructure, enhanced facilities and high grade care of patients are still standing in the mid-way as major challenges in the market growth. Choroidal Neovascularization (CNV) Market size on the basis of geography spans North America, Europe, Asia-Pacific, South America, and Middle East and Africa. As far as the geography is concerned, Asia Pacific is currently leading the market and it is anticipated that it will rise with a robust CAGR in the next couple of years particularly in the countries like China, and India. On the other hand, North America is also emerging in the Choroidal Neovascularization (CNV) market owing to the large number of aged population present in the particular region. It is noted that the region is highly affected by this disease. The key players operating in the Choroidal Neovascularization (CNV) market include Bayer AG, Resolvyx Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Valeant Pharmaceuticals International Inc., and Chengdu Kanghong Biotech Co. Ltd.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Monday, January 7, 2019

Cardiovascular Therapy Market Restraint Analysis & Vendor Landscape by 2025

7 Jan 2019 - Cardiovascular diseases pertain to the blood vessel and heart conditions that can affect the heart valve, cardiac muscle with the circulation system that monitors the blood flow and distribution and the cardiac electrical system which controls the heart rhythm and rate. These complex systems are taken care of by the cardiovascular therapy device market owing to the increasing number of global population being affected by the above mentioned diseases. The cardiovascular therapy market is expected to grow in the forecast period owing to introduction of improved technologies and devices that provide solutions for Cardio vascular diseases.

cardiovascular therapy market

Growth in the global cardiovascular therapy market is attributed to factors owing to increasing worldwide prevalence of chronic CVDs and a higher percentage of aging population. Improvements in treatment capabilities in developing markets owing to technological advancements and innovation is expected to have a positive impact on the demand for cardiovascular thereupatic devices in the medical and healthcare sector. Technological advent with respect to therapeutic devices includes development of extended product life, smaller devices, and surgical improvements. Increase in demand is also driven by increased risk factors (diabetes, smoking, obesity, and hypertension) among people. Key application of in cardiovascular therapy is the hybrid operation rooms market that emphasizes on minimal invasive surgeries. Therefore, Global cardiovascular therapy market is expected to witness a growth owing to increasing demand for minimally invasive surgeries. However, high costs for treatment and safety concerns are major challenges before the market.  Cardiovascular therapy comprises of Anti-hypertensives, anticoagulants, anti-arrhythmic, Antithrombotics and Antidyslipidemics. Global cardiovascular market had a sale of $170bn in 2010 and is expected to have a positive growth in the forecast period. With a share of 40% of the total market, the US continued to be the market leader in this segment.

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/cardiovascular-therapy-market/request-sample

Although there has been a decline in the sales of cardiovascular therapy market due to saturation of key drug categories and an increased generic presence, the US witnessed a steady growth in the market since 2009 and is expected to continue the same trend. Antihypertensives remained the largest drug class in the past few years with global sales of over $37.6bn and an overall market share of over 22%. Angiotensin receptor blockers (ARBs) is expected to remain the most prescribed therapeutic class within antihypertensives driven by key brands such as Cozaar, Diovan, and Avapro. Novartis’s Diovan is the market leader with $3.6bn in sales and the second largest being Benicar with sales of $2.9bn.  The anticoagulants segment is expected to witness significant activity over the forecast period owing to introduction of new drugs such as BoehringerPradaxa/Rendix, Ingelheim's, Bayer-Schering/J&J's, BMS/Pfizer's apixaban, Xarelto and Eli Lilly/Daiichi's Effient which are subjected to intensive R&D activities. Since most of the factor Xa inhibitors are in oral form, they are expected to cater to a wider market.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/cardiovascular-therapy-market

Crestor is expected to witness a steady growth in the market owing to positive trial results that has the capability to strengthen its market position. The positive trial data is likely to result in higher number of recommendations for cholesterol treatment and capture more number of patients with cardiovascular disorders GlaxoSmithKline's (GSK) is expected to have the highest growth among leading players owing to the acquisition of Reliant Pharma. Addition of new drugs such as Lovaza in GSKs portfolio is a key factor that can drive the growth in this segment  In 2010, Antithrombotics recorded a sale of over $18.7bn and a market share of over 11%. Antithrombitics are forecasted to witness a strong growth in the next seven years owing to increase in the commercialization of recently approved products such as Xarelto, Pradaxa and launch of Pfizer/BMS’s apixabanBetter bleeding profile and superior effectiveness of Brilinta (ticagrelor) over Plavix make it major antithrombotic drug that could be a key player in acute coronary syndrome (ACS). A large segment of atherosclerosis patients who do not respond to Plavix can be administered by Brilinta which has a potential therapeutic advantage in atherosclerosis Moreover, its use could be initially confined to acute coronary syndrome (ACS) with no patient monitoring anticipated for postmarketing surveillanceor respiratory or cardiac function requirements. The anti-arrhythmic market is expected to remain a small opportunity as this drug therapy has substantial limitations. New therapeutic standards and benchmarks are expected to be set by Multaq from Sanofi-Aventis owing to its first-line treatment of chronic atrial fibrillation.

Future technologies that are expected to have a positive impact on the market are third generation VADs in cardiac surgery that have the property to easily be implanted, Interventional cardiology that employs innovative therapies such as stem cell therapies and bioabsorbable stents, electrophysiology that focuses on developing implants that does not use lead and advanced endovascular therapy. Key regional segments include Europe, North America, Asia Pacific, Latin Americaand MEAIn 2014, Asia Pacific held the majority of share in global cardiovascular therapy market. Key factors contributing to its large share include prevalence of the target diseases such as hernia and congenital heart diseases. North America is expected to be the fastest growing regions over the forecast period. Health awareness among consumers and presence of improved healthcare infrastructure and pertaining to the availability of new products is expected to increase the use of cardiovascular over the forecast period.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Thursday, January 3, 2019

Teleradiology Market|Information Procurement & Trend Analysis by 2024

3 Jan 2019 - The global Teleradiology Market size is expected to reach USD 8.2 billion by 2024, with a CAGR of over 19.1%. Teleradiology can be defined as the exercise of a radiologist which interprets (reading) medical descriptions about those who are not actually there in the place where the descriptions are generated. Portable imaging companies, hospitals, imperative care facilities and even few personal practices utilize teleradiology services. Teleradiology services can reduce the patient worries by making it achievable for radiologists to offer their services excepting the need to be in the same place. In past few years, teleradiology was barely use in emergency, owing to the internet; this exercise started spreading very fast. Teleradiology makes it easy to remit images as it is to remit emails that have attachment.

Teleradiology Market

Computer programs are their which are devoted exclusively to the spread of radiological pictures. All these development end result in teleradiology service are turning into a noteworthy medical exercise and it carries on rising over the forecast period. Teleradiology services tend to link the breach between the unwarranted requirement and supply of diagnostic services and radiologists around the globe. Teleradiology services assist to transmit radiological images such as MRIs, CTS and MRI from one place to a different place for sharing the descriptive images among other physicians and radiologist. By utilizing technologies such as, Internet, cloud storage ,wide area network, local area network (LAN), telephone lines, as well as voice recognition, image compression, and, advanced graphics processing, teleradiology allows physicians to help their patients from a distant place, in addition ion to which making ‘second opinions ‘becomes much easier Electronic descriptive image transmission in the digital set-up is done with the intention to consult or diagnose, and the expansion and innovation in the area of digital imaging technology is expected to fuel the growth of the global teleradiology market over the forecast period.

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/teleradiology-market/request-sample

Teleradiology generates the highest revenue and is the most mature segment of the industry in the telehealth technologies industry. Advancement in the field of digital technology has transformed the teleradiology services into an effectual means to transfer significant data about patients. Furthermore, technological advancement is expected to propel the growth of the global teleradiology market over the forecasted period. Increasing usage of cellular phones, personal digital assistants, patient monitoring systems and other wireless devices like mobile health services are expected to fuel the growth of the global teleradiology market over the forecasted period. Lack of security for imaging data coupled with the high cost of technology is likely to negatively shape the global teleradiology market over the forecast period. New developments in the field of global teleradiology such as radiology information systems (RIS)) and picture archiving and communication systems (PACS) is expected to open new opportunity for the market over the forecasted period.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/teleradiology-market

Obligation to subordinate the healthcare expenditure has made the healthcare services provider to contract out the analysis of radiology images to budding and low-cost countries. The simplicity of entry for the new entrant in the teleradiology services has resulted in an advanced competition in the market, with a greater number of teleradiology service providers. Aforementioned factor is also expected to drive the growth telerdiology market over the forecast period. Increasing digitalization is also expected to help and improve the teleradiology market over the forecast period On The basis of various imaging modalities the global teleradiology market can be segregated into four major parts such as, magnetic resonance imaging (MRI), computed tomography (CT), nuclear imaging-ray and ultrasound. The X-ray section of global teleradiology market has dominated the larger part of teleradiology market in past few years. Moreover ultrasound imaging is expected to witness more preference over Xray and MRI over the forecasted period owing to fact as the patient is exposed to lesser amount of radiation. CT scan imaging technology is also increasing owing to fact as it allows more ability to detect abnormalities in the pancreas, liver and others. Increasing number of healthcare institution radiologic understanding of CT scans is also increasing. High costs attached and Shortage of technical skill to MRI and nuclear imaging are some of, the parts that will nurture slowly over the forecast period.

On the basis of region Global teleradiology market can be segregated into four parts that are .Asia Pacific, North America, Europe and others. In past few years North America has led the global teleradiology market. The foremost factors accountable for the enlargement of the teleradiology market in North America are rise in expenditure of healthcare companies, rapid innovation in medical approaches and well equipped hospitals. Asia Pacific is expected to see a faster growth rate over the forecast period owing to flourishing new companies in the Countries like India. Teleradiology services provider in India are capable of conquer the shortage of radiology services by providing imaging services to healthcare institution, when radiologists are not accessible in parts of North America such as US. Time zone benefit is one more main thing that has been contributing the growth of teleradiology in India and is expected to drive the growth over the forecast period. The key vendors in Teleradiology market are Teleradiology Solutions, Sectra AB, Cybernet Systems Corporation, Virtual Radiologic, American Telecare Inc, and StatRad.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Friday, December 21, 2018

Predictive Breast Cancer Gene Testing Market Summary & Critical Success Factors (CSFs) by 2025

21 Dec 2018 - Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The global predictive breast cancer gene testing market is segmented on the basis of patient type, end users, and geography.

Predictive Breast Cancer Gene Testing Market

Predictive gene testing mentors are used to detect disease or disorder inherited by analyzing gene mutations associated with particular inherited disease or disorder. Predictive gene testing is also known as presymptomatic testing due to the fact that this test is performed even before the early signs of the disease or disorder are observed and thus enable determining person’s risk of suffering disease or disorder.

Predictive breast cancer gene testing is performed to identify risk of breast cancer in a person having a family history of breast cancer. Early detection of breast cancer enables complete cure of the patient and saving affected breast of the patient. Considering the advantages of early detection of breast cancer, governments worldwide have started taking initiatives to spread awareness about breast cancer and the early detection techniques available in their respective territories.

Growing breast cancer incidences worldwide is another major cause of concern for governments worldwide to focus on awareness programs to reduce the morbidity rate breast cancer. Factors such as increasing incidences of breast cancer globally government worldwide are focused on reducing the morbidity rate of breast cancer and spreading awareness about the available treatmentsin respective countries are driving the predictive breast genetic testing market toward growth. On the other hand expiration of Myriad Genetics’s patient, BRC Analysis gene test in coming year will enable the entry of many market players in this field.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/predictive-breast-cancer-gene-testing-market/request-sample

On the other hand, factors such as acquisition of small market entrants by big players higher initial cost required to start a new facility and the requirement of robust intellectual property to ensure sustenance are restraining the growth of the global predictive breast cancer market.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/predictive-breast-cancer-gene-testing-market

On the basis of patient type, the global predictive breast cancer gene testing market is segmented into age, family history, and gender, and so on. On the basis of end users, the global predictive breast cancer gene testing market is segmented into clinical laboratories, cancer hospitals, and research laboratories and so on. On the basis of geography, the global predictive breast cancer gene testing market is segmented into Europe, North America, Asia Pacific, Latin America and Middle East & Africa.

North America is dominates the predictive breast cancer genetic testing market with the company Myriad Genetics dominating the United States market. The European market is driven by funding from state governments; however, many private companies are entering into European market thereby driving European predictive breast cancer genetic testing industry towards growth. Many market players will be entering into the Asia Pacific region considering rapid growth of medical tourism in the region. The key players of global predictive breast cancer gene testing market are Myriad Genetics, Complete Genomics, Ambry Genetics, Prevention Genetics and Illumina.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Wednesday, December 19, 2018

Flu Protection Kits Market Dynamics And Demand In Emerging Regions by 2025

19 Dec 2018 - Flu is an acronym for “influenza”. Influenza is an infectious disease that is caused by the influenza virus. A person suffering from flu experiences fever, running nose, sore throat, muscle pain, cough, fatigue and headache. Till date, the most dangerous categories of flu’s determined are swine flu and Ebola virus. These bacteria are said to result into fatal consequences for victim as well medical caregivers on detection of mishandling procedures. Flu protection kits thus come into picture to prevent any catastrophic events.

Flu Protection Kits Market

A flu protection kit generally involves gloves, goggles, full body suits, bandage sprays, antibacterial wipes, tissues, environmental friendly bags, sanitizers, sheets and duct tapes. Such equipment helps the medical caregivers to functional efficiently and helps the victim to recover from such virus. Though flu protection kits do not totally eliminate the spread of viruses, they can absolutely reduce the risk of infection to a significant level. With the growing population, flu strains are being discovered frequently and it is obvious that the flu protection kit efficiently fights against harmful bacteria & virus.

The major driving factors for the global flu protection kit are increasing global population, discovery of new and unknown strains of viruses and enhanced healthcare infrastructure in developing markets. In addition, government initiatives to implement proper handling techniques for flu patients have added to the growth of this market. Prominent market players enjoy a significant global position in terms of providing medicine& vaccination in the remote and rural areas of developing countries. However, lack of awareness in public and no sufficient and concrete policies by the government is considered as some of the major hindrance in the global flu protection market. Possibilities such as compromising on safety of patients by providing cost-effective and low-quality flu protection kit is another danger the market witnesses.

Request Sample Copy of this Market Research @https://www.millioninsights.com/industry-reports/flu-protection-kits-market/request-sample

On the basis of geographic segmentation, the global flu protection kits market spans North America, Europe, Middle-East, Asia-Pacific and Africa. North America dominates the global flu protection kits market owing to growing awareness of treatments and enhanced healthcare systems. APAC regions are projected to be the growing markets due to dense population, large and faster growing economies that have started focusing on improving healthcare regulations and infrastructure. The key players in the global flu protection kit market include e-first aid Supplies, Evav8, Pandemic Protection, Life Secure, Bell cross Medical, 1-800 Prepare, Quake Kare and Birdflu Smart.

Browse Full Research Report @https://www.millioninsights.com/industry-reports/flu-protection-kits-market

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Wednesday, December 12, 2018

Breast Implants Market Restraint Analysis & Company Forecast by 2025

12 Dec 2018 - The global Breast Implants Market size was valued at USD 1.2 billion in 2016 and is expected to reach USD 2.0 billion by 2025. According to a FDA about 5-10 million women around the globe have opted for breast implants. Breast implant is an artificial prosthesis made up of a silicone outer shell filled with saline and silicone gel. The breast implant procedure involves reconstruction to improve symmetry after mastectomy or other damages to the breast or enlarging the breasts for cosmetic reasons.

Breast reconstruction requires tissue expanders, which helps in the expansion of breast muscles and skin, following by the permanent insertion of a breast implant after the removal of the tissue expander. The breast implant procedure is performed on an outpatient basis and takes about one to two hours. Women with poor health or severe chronic disease are not considered fit for breast augmentation. Changing lifestyle of people has triggered the demand for cosmetic procedures are projected to boost the growth of breast implant market over the forecast period. In addition, with the introduction of technological advancements such as hyaluronic acid facial filler and two forms stable silicone gel breast implants along with increasing expenditure among consumers pertinent to aesthetic procedures is expected to boost demand for breast implants.

Breast augmentation is used to increase size and improve shape and symmetry of the breasts. However, the limitation of the soft tissue to cover the implants is a key issue. Composite breast implants are useful in such cases. Majority of the women who opt for breast augmentation simply want to balance their upper and lower trunk. Most of the women prefer a rounder and fuller look on top. Adoption of composite breast implants is expected to drive the growth of breast implant market globally during the forecast period. The market is expected to witness substantial growth due to an increase in disposable income of women. With increase in disposable income, more and more women have opted for cosmetic surgeries to improve their appearance and look young. However, the side effects of breast implants are expected to hinder market growth over the forecast period.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/breast-implants-market/request-sample

The market growth is relatively slow in developing countries. However, the market in Asia is expected to witness an increase in its market share over the forecast period owing to substantial increase in disposable income of people in the region along with rising consumer awareness among people of the region of availability of scientific methods to improve looks.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/breast-implants-market

The global Breast implant industry report is a professional and in depth study on the current state of the global Breast Industry. The report offers an overview about the classification, definition, industry chain structure and applications. The analysis of the Breast implant industry is provided by looking at the trends of industry. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Breast implant industry export/import consumption, demand & supply figures, cost price and production value gross margins are also provided. The report also talks about the various factors driving the growth for the industry.

The report also focuses on key players of the industry players providing information such as capacity production, product picture & specification, price, cost, contact information and production value. Downstream raw materials and equipment and upstream demand analysis is also carried out. Breast implant industry development marketing channels and trends are also analyzed. Finally, the viability of new investment projects is assessed and overall research conclusions offered.
Some of the key questions answered by the report are market size and its growth rate. It talks about the key market trends and major growth driving forces of the industry. The report also talks about the key challenges faced by the industry.  Some of the major players in this industry are Allergan, Arion Laboratories, CereplasIdeal Implant, Establishment Labs, GC Aesthetics, Groupesebbin, Guangzhou Wanhe Plastic Materials, Hans Biomed, Mentor Worldwide, PolytechHealth & Aesthetics, Sientra and Silimed.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Friday, November 23, 2018

In Vitro Diagnostics (IVD) Quality Control Market|Share By Application & Forecasts by 2024

23 Nov 2018 - The global IVD Quality Control Market was valued at over USD 847.44 million in 2016 and is anticipated to grow at a 3.7% CAGR. The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.

In Vitro Diagnostics (IVD) Quality Control Market

For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices. These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.
The regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).
The currently undergoing, extensive R&D related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth. For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation. These new regulatory inclusions are anticipated to drive the market growth.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sample

Type Insights

On the type basis, the IVD quality control market is categorized into quality assurance services quality control (QC), and data management. The QC schemes are appropriate to plasma-based, whole blood-based and serum-based products. In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testing

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market

Application Insights

There are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology. Amongst these all, molecular diagnostics is anticipated to be the fastest growing market segment with 4.88% CAGR. The frequent usage of the technologies in the molecular diagnostics, such as gene expression and PCR, high accuracy and specificity are some of the responsible factors associated with its high growth.

End-use Insights

The hospitals market segment was valued the largest market segment of over 46.0% in 2016 owing to the high application of IVD tests in hospitals and the necessity of obedience with the IVD directives for the product traceability. The home care market segment is anticipated to observe a lucrative progression owing to the persistent increase in the usage devices for point-of-care testing. The rise in adoption of microchip technology which is used to handle fluids in IVD equipment, as well as the enhanced production processes and the miniaturization technology are creating efficient point-of-care devices, which are very less susceptible to errors.

Regional Insights

In 2016, largest market share of the IVD quality control market was found to be of North America with revenue of approximately USD over 400.0 million. The existence of a huge number of qualified clinical laboratories, a good distribution network and the rising number of IVD products approvals having assured safety and quality from the regulatory authorities are some of the major driving factors.
The Asia Pacific region had the highest CAGR of over 4.8% owing to the rising government efforts for the standardization of the testing procedures of the clinical laboratory to improve accuracy of results.

Competitive Market Share Insights

Some major key players of the IVD quality control market includes Siemens Healthcare GmbH, Alere, Inc., Roche Diagnostics, Abbott Laboratories, Inc., Qiagen N.V., Hologic, Inc. (Gen-Probe), Bio-Rad Laboratories, Inc., Becton, Dickinson and Company(BD), Quidel Corporation, bioMerieux, Inc., Thermo Fisher Scientific, Inc., Sero AS and Sysmex Corporation.

Market Segments

IVD Quality Control Market Application Outlook, by Revenue (USD Million, 2013 - 2024)
  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others
See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Thursday, November 22, 2018

Asia Pacific In Vitro Diagnostics (IVD) Market Product Estimates, Trend Analysis & Outlook by 2024

22 Nov 2018 - The Asia Pacific in Vitro Diagnostics Market was estimated at USD 12.5 billion in the year 2015. The increasing incidence of infectious and chronic diseases, rising awareness regarding advanced diagnostics solutions as well as technological advancements are expected to boost the in vitro diagnostic market in the Asia Pacific region.

Asia Pacific In Vitro Diagnostics (IVD) Market

The increasing need for rapid diagnostics, rise in healthcare spending, and rapid adoption of advanced technologies in the countries like India and China attributes to the escalating growth rate of the in vitro diagnostics in the region. Moreover, the increasing per capita income in these countries also has led to boost in the in vitro diagnostics market. The other major factors responsible for the growth of the market are increasing gross domestic products, and disposable income. High population, cheap labor, unmet needs of targeted population, as well as escalating incidence and prevalence of infectious diseases have triggered major global players to enter the regional market. The increasing number of funds and more investments in the emerging economies has also helped to boost the demand for IVD products in the region. However, the strict regulatory policies are expected to the restraint the market growth of IVD.

Product Insights

On the basis of products, the segmentation includes reagents, instruments, and services. As of 2015, the reagents and kits segment accounted for the largest share in the region. Repetitive purchase of reagents and kits has led to the increasing demand of these products.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/asia-pacific-in-vitro-diagnostics-ivd-market/request-sample

The instruments segment is anticipated to witness growth at significant rate during the study period. Introduction of advanced analyzers with low turnaround time is expected to flourish the regional market in the near future. For instance, in April 2017, bioMérieux announced that its new fully automated blood culture system, BacT/ALERT VIRTUO, received 510(k) clearance from the U.S. Food and Drug Administration.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/asia-pacific-in-vitro-diagnostics-ivd-market

Application Insights

On the basis of application, the market is classified into oncology, infectious diseases, HIV, cardiology, autoimmune diseases, nephrology, and drug testing. The infectious segment is estimated to be the largest among all due to high incidence rate of the infectious diseases in the Asia Pacific region.
Moreover, the increasing incidence of HIV has further led to the increase in demand for rapid IVD tests. In addition, the increasing awareness among the people regarding the new test methods has led to augment the in vitro diagnostics market in the Asia Pacific region.

End Use Insights

On the basis of the end use, the IVD market in the Asia Pacific region is classified into the hospitals, laboratories, homecare diagnostics, and others. Being the primary healthcare center, hospital held the largest revenue share in 2015.
Homecare diagnostics is anticipated to grow at the highest CAGR during the forecast period. Growing elderly population base, rising demand for rapid testing, and increasing initiatives for reducing prolonged hospital stays are some of the key factors supporting market growth.

Regional Insights

The regional IVD market is classified in to Japan, India, and China. China is projected to grow at the highest CAGR during the study period. The increasing per capita income and rising GDP are factors responsible for the growth of these markets.
Moreover, the developing economies such as that of India have attracted various companies to invest in these countries. The increasing population also has led to the increased demand of IVD in the Asia Pacific region.

Competitive market Share Insights

The major players include Affymetrix, Inc., Danaher Corporation, Alere, Inc, Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, BioMerieux, Inc., Vela Diagnostics, Inc., Siemens Healthcare Diagnostics, Inc., among others.
In order to gain a competitive edge in the market, major players have undertaken several organic as well as inorganic strategies. Some of the key strategies include new product launch and development, geographic expansion, mergers, acquisition, and agreement among others.

Market Segment:

 Asia Pacific In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2013 - 2024)
  • Reagents
  • Instruments
  • Services
See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Friday, November 16, 2018

Coagulation Analyzers and Reagents Market Segmentation & Growth Prospects 2024

16 Nov 2018 - The global Coagulation Analyzers & Reagents Market size was worth USD 3.3 billion in 2015 and is likely to grow at a CAGR of over 10.2% over the forecast period. The growth of this market is supported by increasing number of lifestyle disorders and chronic blood related disorders.

Coagulation Analyzers and Reagents Market

The increase in the volume of testing can be attributed to the augmented awareness among people towards lifestyle and blood disorders which is expected to further improve the diagnostic rate and preventive care management. The study covers developing countries which are undergoing paradigm shift and are highly investing government funds for the procurement and installation of these medical devices in the public healthcare facilities. Specifically, for the developing nations of the Asia Pacific and Middle East region factors such as increased geriatric population, rapid growth in foreign investments and rising prevalence of lifestyle disorders are expected to be support market growth. Another major driving force identified is the increased incidence of haemophilia as per a report published by the WHO, resulting in the industry growth and rising installation base and expansion of these medical devices in the healthcare facilities.

Product Insights

Analyzers are one of the most critical and important equipment used for diagnosis, currently owing to multiple factors and thus are expected to have a lucrative CAGR in the forecasted period. The major factors driving the growth of this segment are increasing incidences of the lifestyle disorders such as diabetes, cardiovascular disorders and obesity combined with developing healthcare infrastructure and spending on healthcare.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/coagulation-analyzers-reagents-market/request-sample

The factor expected to propel the growth of the diagnostics market, are providing timely and quality care to the patients which in turn is expected to hike the demand for hemostasis analyzers. The class of hemostasis analyzers recording the majority of the shares in 2015 is the clinical laboratory analyzers which are predominantly used in the hospitals for the hematological analysis of the patients on a daily basis.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/coagulation-analyzers-reagents-market

Shares up to 65.0% were held by the Consumables segments which were further sub segmented to stains and reagents. Due to the pre requisite of having reagents for each and every test, their demand also increases with increase in diagnostic volume, hence a high repository of orders are placed by the hospitals. The sales of these consumables are expected to be boosted by the higher volumes of testing and development of new and innovative assays.

Technological Insights

Over the period of forecast, optical technology is estimated to hold majority of the shares due to the increasing combination of photo optical method with immunologics and chromogenics. This combination has led to the development of multipurpose, high performance optical hemostasis analyzers.
This segment is further divided into chromogenic/immunological/photo optical and others. The other segment includes technologies that are patented by Beckman Coulter Inc., Instrumentation Laboratory, Siemens Healthcare and others.

Test Type Insights

In the context of test types, maximum shares were recorded to be held by the prothrombin segment followed by the APTT test segment in 2015. High popularity among the physicians for the aforementioned tests is responsible for the large shares.
The APTT test is majorly used in the detection of coagulation inhibitors, inherited and acquired abnormalities of the intrinsic coagulation pathway, liver diseases, monitoring of heparin therapy and Disseminated Intravascular Coagulation (DIC). The various principles on which this test is based are electrochemical and photo optical.

End-use Insights

The major drivers for the end-use segment of the coagulation analyzer market are rapid expansion in primary healthcare centers and hospitals, favorable government regulations in the healthcare facilities combined with availability of advanced equipment with capacity to perform high accuracy multiple tests.
The major end users of this market are research institutes, hospitals, diagnostic centers and others. In 2015, diagnostic centers dominated the market due to the high rates of outsourcing of the diagnostic tests to these centers, but in the forecasted period hospitals are expected to grow due higher number of installations of analyzers and consumables on the basis of hospital needs.

Regional Insights

North America held majority of the revenue shares in 2015 for the global market, which is around 35.0%. The major drivers for this region are increasing prevalence of disorders belonging to the cardio metabolic class like Pulmonary Embolism (PE), and Deep Vein Thrombosis (DVT) and presence of well-established healthcare services.
Regions such as Middle East and Africa are expected to show higher growth rates due to the growing number of hospitals, health centers and clinics combined with highly skilled professionals to provide useful, appropriate and safe healthcare facilities. In 2012 Ministry of Health and Ministry of Public Works announced an investment worth USD 4.4 billion aimed at expansion and replacement of nine operating hospitals in the span of next ten years, following which a National Health Plan was created for the span of 2010-2014 focusing on major expansions in the healthcare sector.

Competitive Insights

Major players in the market are namely Siemens Healthcare, Instrumentation Laboratory, and Roche Diagnostics, Alere, Inc., Thermo Fischer Scientific, and Nihon Kohden. Due to the easy global accessibility in this market, the major players are already present in across various countries and are competing to secure the higher market share.
Distributions of these products are majorly done by third party vendors presently. For example, Sysmex entered into an agreement with Dade Behring for the distribution of their products, which is now a part of Siemens Healthcare Diagnostics. But on the contrary this trend is expected to change in the forecasted period due to the increase in the investment to establish offices for distribution within multiple regions by the players leading to the rise in the momentum of direct supply agreements in the regions over the period of forecast.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Thursday, November 8, 2018

In Vitro Diagnostics (IVD) Market Drivers Analysis, Overview And Outlook To 2020

7 Nov 2018 - The global In Vitro Diagnostics (IVD) Market size was estimated at USD 60.17 billion in 2016. The rise in prevalence of gastrointestinal disorders and sexually transmitted diseases, coupled with increase in requirement for large-scale population screening will grow the market in the forecast years. For instance, new generation cancer diagnostics are in demand for identifying if a particular medicine or treatment would be effective on the patients. Innovations and advancements in these technologies will help to grow the market, further leading to introduction of new test applications.

In Vitro Diagnostics (IVD) Market

The rise in the base population with increase in command for diagnostic testing will help to boost the IVD market. Also, rising incidence of diabetes is expected to increase the demand of proper diagnostics for patients who use these devices regularly to examine their blood glucose level. According to the National Diabetes Statistics Report 2014, approximately 9.3% of total of the U.S. population or 29.1 million people of the total have diabetes and around 27.8% of the U.S population or 8.1 million people are undiagnosed and are suffering from diabetes
Various organizations are working to observe the industry. For example, BIVDA, an union of companies with high involvement and interest which represents manufacturers and distributors implementing in the UK is actively involved in commercialization of novel diagnostics. Rising importance of the diagnosis in patient care and swiftly altering healthcare environment, along with the increase in awareness about the diseases, will help to promote the IVD market in the coming years. Increasing demand for the detection of different diseases which includes upper and lower respiratory tract infections such as RSV, influenza, Legionaries disease, pneumonia and malaria will help to drive the growth.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-market/request-sample

Product Insights

Professional diagnostic were found to be the largest segment with revenues of USD 41.34 billion in 2016. The increasing base of target population with unmet medical needs which includes infectious diseases and the potential of this segment to offer reliable and rapid diagnostics will lead segment growth.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-market

Tissue diagnostics is expected to grow at a CAGR of 10.2% from 2014 to 2020 due to increasing prevalence rates of cancer thus raising the demand for lab automation. In accordance to the National Cancer Institute, in 2015, the most common cancers are likely to be of bronchus and lung, rectum and colon, breast, melanoma of the skin, and prostate. Furthermore, approximately 1,658,370 new cancer cases are probable to be diagnosed in the U.S. in coming year, which is anticipated to help increase the requirement for tissue diagnostics segment.

Regional Insight

North America was the major region and is expected to grow owing to incidence of chronic disorders which includes respiratory diseases and cancer in this region. Europe was estimated at over USD 23.92 billion in 2016 and is predicted to rise due to growing prevalence rate of cancer, tuberculosis and pneumonia in the coming years.
Asia Pacific is followed by Europe, which accounted for over 21.0% of market share in 2016. Growing clinical research, government initiatives in order to enhance the diagnostics with the increasing per capita healthcare expenditure will help to promote the growth over the forecast period.
The IVD majorly adds to the health and wellbeing of the European economy. Over 40,000 IVD products are available in the market which caters to the needs of specialists and patients for a wide array of conditions.

Competitive Insights

Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, Abbott Laboratories, and Beckman Coulter Inc. are the key players of the market. These players provide different solutions such as various required services, reagents, and instruments. The companies are occupied in wide R&D activities to gain sustainability and commercialize new products in this segment which is expected to increase the market rivalry.
In April 2015, Abbott and Sekisui declared a conformity to offer around the globe coagulation testing solutions. As per the conformity, the elite distributor is Abbott of CP3000 coagulation instrument (Sekisui), in Europe, the U.S., and regions that approve CE mark.
In December 2014, the product line was expanded by Roche for testing of human tissue and organ for next-generation blood screening assays. Cobas MPX and cobas WNX assays were introduced for usage in human organ and tissue testing, hence growing the range of permitted uses for the cobas 6800/8800 assays and systems

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare